lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients

@inproceedings{Zou2017lncRNAsPA,
  title={lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients},
  author={Hecun Zou and Lan-xiang Wu and Yonglong Yang and Shuang Li and Ying Mei and Yong-Bin Liu and Lihua Zhang and Yu Cheng and Hong-hao Zhou},
  booktitle={Oncotarget},
  year={2017}
}
Diffuse gliomas are well known malignant brain tumors. Long non-coding RNAs (lncRNAs), a type of RNA transcript with more than 200 nucleotides, involve in tumorigenesis and development of various cancers. This study focused on identifying differentially expressed lncRNAs in gliomas based on gene expression profiling, and chose certain lncRNAs PVT1, CYTOR, HAR1A and MIAT, which changed with significant differences. Further analysis of TCGA and GEO data revealed that the expressions of PVT1 and… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 48 references

Similar Papers

Loading similar papers…